Fundraising FoxKadis Bio
1 known investors
Find your way into Kadis Bio
Sign up to see every warm intro you have to Kadis Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kadis Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kadis Bio develops human induced pluripotent stem cell (hiPSC) therapies for treating cardiovascular disease, targeting peripheral arterial disease and critical limb ischemia. Its approach aims to promote blood vessel growth for conditions such as ischemic heart disease, diabetic retinopathy and neuropathy, and wound healing.
Investors · 1
Frequently asked questions
- What does Kadis Bio do?
- Kadis Bio develops human induced pluripotent stem cell (hiPSC) therapies for treating cardiovascular disease, targeting peripheral arterial disease and critical limb ischemia. Its approach aims to promote blood vessel growth for conditions such as ischemic heart disease, diabetic retinopathy and neuropathy, and wound healing.
- Who are Kadis Bio's investors?
- Kadis Bio's investors include Premier Partners.